Hepatotoxicity of Antitubercular Treatments
- 1 December 1996
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 15 (6), 394-405
- https://doi.org/10.2165/00002018-199615060-00004
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Hepatotoxicity due to Antituberculosis TherapyJournal of Clinical Gastroenterology, 1996
- Cholestatic hepatitis related to quinolones: a report of two casesJournal of Hepatology, 1995
- An Outbreak of Multidrug-Resistant Tuberculosis among Hospitalized Patients with the Acquired Immunodeficiency SyndromeThe New England Journal of Medicine, 1992
- Fatal hepatotoxicity of anti-tubercular chemotherapyThe Lancet, 1991
- Tuberculosis in Patients with Human Immunodeficiency Virus InfectionThe New England Journal of Medicine, 1991
- Isoniazid-related hepatotoxicity: A study of the effect of rifampicin administration on the metabolism of acetylisoniazid in manTubercle, 1989
- Cholestatic jaundice caused by ethambutol.BMJ, 1986
- Adverse Effects of RifampinClinical Infectious Diseases, 1983
- PYRAZINAMIDE FULMINANT HEPATITIS: AN OLD HEPATOTOXIN STRIKES AGAINThe Lancet, 1981
- A controlled trial of six months chemotherapy in pulmonary tuberculosis: First report: Results during chemotherapyRespiratory Medicine, 1981